Grants Search Results

This grant supports clinical research staff to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Nurse Coordinator who works with new patients in the combined Adolescent and Young Adult and Cancer Survivor Clinic, to ensure they have access to the best clinical trials for their cancer.

Through this partnership with the Children's Cancer Foundation, proceeds from St. Baldrick's head-shaving events in Hong Kong support life-saving childhood cancer research in Hong Kong. The St. Baldrick's Foundation is proud to partner with the Children's Cancer Foundation and has been doing so since 2008. This grant has funded two projects. The first project is an extension of a previous grant. Researchers collect the tissues of all pediatric brain tumors in Hong Kong to review and perform special tests. The results will refine diagnoses and categorization, offers much better prognosis and more precise therapy. The second project is also an extension of a previous grant, building on the work showing that rituximab combined with chemotherapy improves survival rate in patients with acute lymphoblastic leukemia. This year's extension will study how adding bortezomib to rituximab and chemotherapy improves remission rates.

This grant supports a Clinical Research Nurse Coordinator for the Adolescent Young Adult Cancer Center Program at Bon Secours St. Francis Health System, to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports bilingual clinical research staff to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a patient navigator to ensure that more adolescents and young adults (AYA) can be treated on clinical trials, often their best hope for a cure.

This grant funds a Nurse Practitioner for the the Childhood Cancer Survivorship Program. The program also provides critical patient data for survivorship researchers.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Associate to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

This grant supports a Clinical Research Coordinator to support the Signature Precision Medicine Study and ensure that more kids can be treated on clinical trials, often their best hope for a cure.

The AJ Renner Memorial St. Baldrick's Infrastructure Grant funds the Nurse Researchers in the UIC/Rush/Stroger COG Program to ensure more kids can be treated on clinical trials, often their best hope for a cure. AJ Renner was an amazing volunteer and donor in Chicago and a champion for kids fighting cancer.

This grant supports a Clinical Research Associate to facilitate early-phase pediatric oncology clinical trials in the South Plains Oncology Consortium (SPOC) and ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Memorial Health University Medical Center has developed a dedicated Adolescent and young adult (AYA) cancer program to provide better care and to encourage participation of these patients in clinical trials that will ultimately lead to better treatment outcomes.This grant supports a Clinical Oncology Social Worker to support the AYA Cancer Program and ensure that more AYA patients can be treated on clinical trials, often their best hope for a cure.

This grant provides infrastructure support for research equipment to allow University of South Carolina investigators to advance pediatric cancer treatment research.

This grant supports a Research Nurse to ensure that more kids can be treated on clinical trials, often their best hope for a cure.

Do you ever get a cold sore on your lip, or know someone who does? That sore is caused by a virus that destroys the cells in your lip. As the virus spreads, the sore gets bigger. Viruses are great at killing cells and spreading. But, the sore eventually goes away because the immune system attacks the infected cells, killing them and stopping the viral infection, allowing your lip to heal. Imagine if we could get both the virus and the immune system to kill cancer cells instead of lip cells! Previously Dr. Haworth's team used a safe version of the cold sore virus to infect a common type of hard-to-treat childhood cancer cells. The virus directly killed cancer cells and caused the immune system to attack the cancer cells that the virus missed. Dr. Haworth's team is testing ways to make the virus and immune system work better together. Dr. Haworth is infecting model tumors with the virus, and giving immune cells designed to attack the tumor, hypothesizing that giving both virus and immune cells will cure the tumor. Awarded at The Research Institute at Nationwide and transferred to St. Jude Children's Research Hospital.

This grant supports a scientific meeting to plan a clinical trial for osteosarcoma, focused on using genomic data to define subgroups to receive targeted therapy combined with chemotherapy.

Rhabdoid tumors are highly aggressive cancers that affect infants. Current treatments mostly fail, or provoke severe long-term side-effects. Among promising innovative treatments, immunotherapy has few side-effects and show spectacular efficacy in some adult cancers. Immunotherapy restores the ability of our immune system to reject cancer cells, thanks to their numerous genetic abnormalities. Dr. Bourdeaut's project consists in understanding how rhabdoid tumor cells, which harbor no genetic abnormality, may escape this rejection or, in contrary, how they may be recognized by the immune system. Understanding this may have unexpected and broad consequences for the treatment of RT and other poorly mutated cancers.

This institution is a member of a research consortium which is being funded by St. Baldrick's: Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium. For a description of this project, see the consortium grant made to the lead institution: Baylor College of Medicine, Houston, TX.